Is your portfolio Capex-ready? Top Stocks to Watch Out for High CAPex driven growth

Buckle up and forget the snooze-fest of balance sheets; we’re diving into the riveting world of Capex growth. Picture this as the stock market’s version of a blockbuster movie – with Mphasis flexing its Salesforce muscles, Finolex Cables stretching its communication cords, and Century Plyboards planning a boardroom revolution. Grab your popcorn, because these Capex tales are about to turn your financial spreadsheet into a page-turner!

Software & Services: Mphasis Takes the Lead

• In the digital realm, Mphasis is set to redefine the game with an astronomical estimated Capex growth of 567% in FY24. The acquisition of Silverline for Rs 1,100.7 crore promises to turbocharge its Salesforce capabilities, paving the way for a technology-fuelled future.
• Zensar Technologies and Cyient follow suit with impressive growth projections of 182.6% and 167%, respectively.

Consumer Durables: Finolex Cables Surge Ahead

• Finolex Cables shines in the consumer durables sector, boasting the highest estimated Capex growth of 736.2% in FY24. With a Rs 400 crore investment plan, the company aims to expand capacities across communication, solar, automotive, and construction cables.
• Kaynes Technology India and KEI Industries are not far behind, anticipating growth of 304.3% and 298.7%, respectively.

Automobiles & Auto Components: Asahi India Glass Takes the Fast Lane

• Asahi India Glass accelerates with an estimated Capex growth of 389.9% in FY24, allocating Rs 1,400 crore for maintenance and a groundbreaking greenfield project.
• Samvardhana Motherson International is also on the move, projecting a growth of 213.2%.

Chemical and Pharma: PI Industries Leads the Charge

• PI Industries leads the chemical sector with an astounding estimated Capex growth of 324% for FY24. With strategic investments aimed at enhancing capacity and technological capabilities, the company is set to make waves.
• In pharmaceuticals, Gland Pharma takes the lead with a 350.6% growth estimate, followed by Ipca Laboratories at 165.6%.

Diversified Consumer Services: Cera Sanitaryware Shaping the Future

• Cera Sanitaryware emerges as a frontrunner in diversified consumer services, boasting an estimated Capex growth of 218.1% in FY24. With capacity expansions and strategic land acquisitions, the company is making bold moves to meet growing demands.
• Max Healthcare Institute is also poised for significant growth, anticipating a 207.3% increase in Capex.

Notable Stocks Making Waves

• In the vast sea of market players, several stocks stand out with remarkable Capex growth estimates. AMC Nippon Life India Asset Management leads with a staggering 347%.
• Chambal Fertilisers and Chemicals follows at 278.4%, and Emami makes its mark with a noteworthy 239.8% growth projection.

Century Plyboards: Paving the Way for Tomorrow’s Innovations

• Century Plyboards charts an ambitious course with an estimated Capex growth of 260.6% for FY24. The planned Rs 450 crore Capex in FY25 aims at expanding particle board production in Chennai, setting the stage for enhanced capacities across various segments.

General Industries: Hitachi Energy India Spearheads Expansion

• In general industries, Hitachi Energy India steals the spotlight with a staggering estimated Capex growth of 735.4% for FY24. Fuelled by plans to add 45 new data centres, the company aligns seamlessly with India’s data-driven future.
• Timken India follows suit with a robust 527.3% growth projection, diversifying its presence across capex-sensitive sectors.

Jindal Saw, RHI Magnesita, Praj Industries, and CG Power: Shaping the Industrial Landscape

• Jindal Saw leads the pack in FY24 with an estimated Capex growth of 462.8%.
• RHI Magnesita and Praj Industries closely trail behind, showcasing growth projections of 284% and 283%, respectively. Praj Industries earmarks Rs 100 crore for Praj GenX in the Energy Transition & Climate Action (ETCA) sector, demonstrating a commitment to sustainable solutions.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.